Exane Derivatives’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-9,087
| Closed | -$122K | – | 1084 |
|
|
2021
Q3 | $122K | Buy |
9,087
+2,346
| +35% | +$31.5K | 0.03% | 487 |
|
|
2021
Q2 | $130K | Buy |
6,741
+631
| +10% | +$12.2K | 0.03% | 502 |
|
|
2021
Q1 | $147K | Sell |
6,110
-40
| -0.7% | -$962 | 0.04% | 335 |
|
|
2020
Q4 | $111K | Buy |
6,150
+320
| +5% | +$5.76K | 0.03% | 377 |
|
|
2020
Q3 | $67.3K | Buy |
5,830
+63
| +1% | +$728 | 0.02% | 335 |
|
|
2020
Q2 | $140K | Buy |
5,767
+29
| +0.5% | +$703 | 0.04% | 227 |
|
|
2020
Q1 | $63.2K | Buy |
+5,738
| New | +$63.2K | 0.02% | 318 |
|